首页> 美国卫生研究院文献>AAPS PharmSciTech >A Drug-in-Adhesive Matrix Based on Thermoplastic Elastomer: Evaluation of Percutaneous Absorption Adhesion and Skin Irritation
【2h】

A Drug-in-Adhesive Matrix Based on Thermoplastic Elastomer: Evaluation of Percutaneous Absorption Adhesion and Skin Irritation

机译:基于热塑性弹性体的胶粘剂基质:对经皮吸收粘附和皮肤刺激性的评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A novel drug-in-adhesive matrix was designed and prepared. A thermoplastic elastomer, styrene–isoprene–styrene (SIS) block copolymer, in combination with tackifying resin and plasticizer, was employed to compose the matrix. Capsaicin was selected as the model drug. The drug percutaneous absorption, adhesion properties, and skin irritation were investigated. The results suggested that the diffusion through SIS matrix was the rate-limiting step of capsaicin percutaneous absorption. [SI] content in SIS and SIS proportions put important effects on drug penetration and adhesion properties. The chemical enhancers had strong interactions with the matrix and gave small effect on enhancement of drug skin permeation. The in vivo absorption of samples showed low drug plasma peaks and a steady and constant plasma level for a long period. These results suggested that the possible side effects of drug were attenuated, and the pharmacological effects were enhanced with an extended therapeutic period after application of SIS matrix. The significant differences in pharmacokinetic parameters produced by different formulations demonstrated the influences of SIS copolymer on drug penetrability. Furthermore, the result of skin toxicity test showed that no skin irritation occurred in guinea pig skin after transdermal administration of formulations.
机译:设计并制备了新型的药物包胶基质。热塑性弹性体,苯乙烯-异戊二烯-苯乙烯(SIS)嵌段共聚物,与增粘树脂和增塑剂相结合,构成了基体。选择辣椒素作为模型药物。研究了药物的经皮吸收,粘附特性和皮肤刺激性。结果表明,通过SIS基质的扩散是辣椒素经皮吸收的限速步骤。 SIS中的[SI]含量和SIS比例对药物渗透性和黏附特性产生重要影响。化学促进剂与基质的相互作用很强,对增强药物皮肤的渗透作用很小。样品的体内吸收显示出较低的药物血浆峰和长期稳定且恒定的血浆水平。这些结果表明,在应用SIS基质后,随着治疗时间的延长,药物的可能的副作用得到了减轻,药理作用得到了增强。由不同配方产生的药代动力学参数的显着差异证明了SIS共聚物对药物渗透性的影响。此外,皮肤毒性试验的结果表明,经皮给药制剂后在豚鼠皮肤中未发生皮肤刺激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号